
Nutraceutical Contract Manufacturing Services Market Report 2026
Global Outlook – By Product (Dietary Supplements, Functional Food And Beverages), By Dosage Form (Tablets, Capsules, Liquid Oral, Powder In Sachet Or Jar, Gummies, Energy Bars, Other Forms), By End User (Big Pharmaceutical Companies, Small And Medium Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Nutraceutical Contract Manufacturing Services Market Overview
• Nutraceutical Contract Manufacturing Services market size has reached to $194.89 billion in 2025 • Expected to grow to $340.8 billion in 2030 at a compound annual growth rate (CAGR) of 11.8% • Growth Driver: Nutraceutical Contract Manufacturing Thrives Amidst Chronic Disease Prevalence • Market Trend: Nutraceutical Development Platforms For Profitability • Asia-Pacific was the largest region in 2025.What Is Covered Under Nutraceutical Contract Manufacturing Services Market?
Nutraceutical contract manufacturing services refer to outsourcing the manufacturing and production of nutraceutical products to specialized contract manufacturing companies. Nutraceuticals combine the benefits of nutrition and pharmaceuticals, including dietary supplements, functional foods, and herbal products, which are consumed for their potential health and wellness benefits. The main product types of nutraceutical contract manufacturing services are dietary supplements, functional food, and beverages. Dietary supplements are products that contain vitamins, minerals, herbs, botanicals, amino acids, or other dietary ingredients intended to supplement an individual's diet. The various dosage forms include tablets, capsules, liquid oral, powder in sachet or jar, gummies, energy bars, and others that are used by various end users such as big pharmaceutical companies, small and medium-sized pharmaceutical companies, generic pharmaceutical companies, and others.
What Is The Nutraceutical Contract Manufacturing Services Market Size and Share 2026?
The nutraceutical contract manufacturing services market size has grown rapidly in recent years. It will grow from $194.89 billion in 2025 to $218.34 billion in 2026 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to growth in dietary supplement consumption, expansion of health and wellness awareness, rise in pharmaceutical outsourcing, increasing preventive healthcare focus, availability of contract manufacturing facilities.What Is The Nutraceutical Contract Manufacturing Services Market Growth Forecast?
The nutraceutical contract manufacturing services market size is expected to see rapid growth in the next few years. It will grow to $340.8 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to growth in personalized nutrition demand, increasing functional food consumption, expansion of nutraceutical brands, rising global health consciousness, advancements in formulation technologies. Major trends in the forecast period include rising outsourcing of nutraceutical production, growing demand for custom formulations, expansion of clean label manufacturing, increased focus on regulatory compliance, growth of functional food and supplement production.Global Nutraceutical Contract Manufacturing Services Market Segmentation
1) By Product: Dietary Supplements, Functional Food And Beverages 2) By Dosage Form: Tablets, Capsules, Liquid Oral, Powder In Sachet Or Jar, Gummies, Energy Bars, Other Forms 3) By End User: Big Pharmaceutical Companies, Small And Medium Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users Subsegments: 1) By Dietary Supplements: Vitamins And Minerals, Herbal Supplements, Protein Supplements, Omega Fatty Acids, Probiotics, Other Dietary Supplements 2) By Functional Food And Beverages: Functional Beverages, Functional Foods, Nutrient-Enriched Foods, Other Functional ProductsWhat Is The Driver Of The Nutraceutical Contract Manufacturing Services Market?
The rising prevalence of chronic diseases is expected to drive the growth of the nutraceutical contract manufacturing services market going forward. Chronic disease refers to a health condition or disease that is long-lasting in its effects, usually lasting for three months or longer, and may get worse over time. Nutraceutical contract manufacturing provides nutraceutical brands with accelerated product development and production timelines for high-quality, customized nutraceutical products that can help manage and prevent chronic diseases. For instance, in April 2025, according to the U.S. Centers for Disease Control and Prevention (CDC), a US-based government public health agency, the share of U.S. adults with at least one chronic condition was 76.4%, while 51.4% of adults reported having multiple chronic conditions, reflecting a high and sustained prevalence compared to previous years. Therefore, the rising prevalence of chronic diseases is expected to propel the growth of the nutraceutical contract manufacturing services industry.Key Players In The Global Nutraceutical Contract Manufacturing Services Market
Major companies operating in the nutraceutical contract manufacturing services market are Nutra Manufacturing Inc., Royal DSM, Lonza Group AG, Glanbia Plc., Catalent Inc., Ashland Global Holdings Inc., American Health Foundations Inc., Robinson Pharma Inc., Gemini Pharmaceuticals Inc., Nutrivo, Menadiona, NutraLab Canada Ltd., Martínez Nieto, Rain Nutrience Ltd., Biovencer Healthcare Pvt Ltd., NutraScience Labs, ABH Pharma Inc., NutraPak USA, Biotrex Nutraceuticals, Nutrafill LLC, Quest Nutra Pharma, VestanutraGlobal Nutraceutical Contract Manufacturing Services Market Trends and Insights
Major companies operating in the nutraceutical contract manufacturing facilities market are developing innovative platforms such as microbiome therapeutic platform to enhance host–microbe functional interactions. Microbiome therapeutic platform refers to an integrated scientific and technological framework designed to analyze, engineer, and modulate microbial communities within the human body to achieve therapeutic outcomes. For instance, in November 2023, Lallemand Health Solutions, a Canada-based probiotics manufacturer launched Expert'Biome CDMO. A cutting-edge contract manufacturing and development platform designed to aid partners in advancing next-generation strains. The platform encompasses services such as strain characterization, scale-up, synthesis of drugs, and other manufacturing steps. The manufacturing facilities adhere to the highest quality standards, including cGMP Pharma, and underpinned by internationally recognized accreditations, Expert'Biome ensures excellence in investigational and commercial biological product development.What Are Latest Mergers And Acquisitions In The Nutraceutical Contract Manufacturing Services Market?
In January 2023, Sirio Pharma, a China-based contract manufacturer and developer of nutritional and dietary supplement products, acquired Best Formulations for an undisclosed amount. Through this acquisition, Sirio Pharma aims to enhance its global presence and deliver high-quality products to customers worldwide, catering to the production requirements of both international and local brands. Best Formulations is a US-based contract manufacturer specializing in nutritional supplements and personal care products.Regional Outlook
Asia-Pacific was the largest region in the nutraceutical contract manufacturing services market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Nutraceutical Contract Manufacturing Services Market?
The nutraceutical contract manufacturing services market includes revenues earned by entities by providing formulation development, ingredient sourcing, screen printing and labeling, and quality control services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Nutraceutical Contract Manufacturing Services Market Report 2026?
The nutraceutical contract manufacturing services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nutraceutical contract manufacturing services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Nutraceutical Contract Manufacturing Services Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $218.34 billion |
| Revenue Forecast In 2035 | $340.8 billion |
| Growth Rate | CAGR of 11.8% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Dosage Form, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Nutra Manufacturing Inc., Royal DSM, Lonza Group AG, Glanbia Plc., Catalent Inc., Ashland Global Holdings Inc., American Health Foundations Inc., Robinson Pharma Inc., Gemini Pharmaceuticals Inc., Nutrivo, Menadiona, NutraLab Canada Ltd., Martínez Nieto, Rain Nutrience Ltd., Biovencer Healthcare Pvt Ltd., NutraScience Labs, ABH Pharma Inc., NutraPak USA, Biotrex Nutraceuticals, Nutrafill LLC, Quest Nutra Pharma, Vestanutra |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
